Medicines Usage Reviews
TPP2 – Semester 2
Medicines Reconciliation
• The aim of medicines reconciliation in a hospital setting is to ensure that the prescribed medicines
correspond to those that the patient was taking before admission; it is more than just taking a drug
history, and requires consideration of the three C’s; checking, collecting and communicating.
• Medicines reconciliation seeks to minimise harm to the patient caused by medication errors,
prescribing errors and missed doses, whilst simultaneously reducing admissions and
readmissions that are caused by medication harm. It provides prescribers with a fuller information
timeline that helps improve patient safety.
The Three C’s
• Collecting a medication background, checking current medications against prescribed
medications/medicines bought in with the patient, and communicating any changes or
discrepancies is the basis of how medicines reconciliation can provide benefit to patients.
• Sources of drug history include; medicines the patient has bought in with them, prescriptions the
patient has on them, verbal communication with the patient, verbal communication with a patients’
relative that is present, information obtained through electronic databases and phone calls to GPs
or pharmacies.
• Checking medications is important in the detection of intended changes, and unintended changes.
Intended changes to medication will have been agreed with the prescriber, whereas unintended
changes can arise due to errors, omissions and additions.
• Communication is important, so that the patient is involved in their care and can make choices
where appropriate. Consent is also important in this regard. The clinician caring for the patient
should be free to discuss discrepancies, alter prescriptions if necessary and inform the patient
about changes. Changes should also be documented on the patient’s medical notes, the patient’s
drug chart and should be written in the hospital discharge summary.
MUR
• Medicines Usage Reviews (MURs) were introduced in 2005 as an advanced service for
community pharmacies. They focus on making sure patients understand how to use their
medications, when to use them and why they must use them.
• Pharmacists can decide which patients to offer MURs to, but at least half of the patients must fall
under National Patient Targets.
• National Patient Targets are groups of patients to which MURs should be offered, and include the
following groups; those on at-risk medications (i.e. anticoagulants, NSAIDs, antiplatelets and
diuretics); patients with a respiratory disease; patients who have recently been discharged from
hospital, having had a medication change during their stay; and patients with or who are at risk of
cardiovascular disease and regularly being prescribed at least four medicines.
• An MUR is different from Clinical Medication Reviews and Medication Reviews. The former is
consultation undertaken to assess patient’s illness and drug treatment (not conducted by non-
prescribing pharmacists). The latter is a review undertaken to optimise impact of therapy, reduce
harm caused by medications, and reduce wastage.
• MURs allow the patient to check their understanding of their own condition(s) and a professional
to check the effective use of medicines. The pharmacist is ideally placed to detect potential
formulation issues, and recommend changes to dose, strength or product. They are also well-
placed to identify adverse effects that may require reporting.
Levels of Review
• MURs are level 1 reviews, that are conducted by pharmacists in the presence of the patient, with
no access to patient notes.
• Medication reviews are level 2 services that are conducted by doctors, specialist nurses, CCG
pharmacists and NMPs in the absence of the patient, with access to full patient records.
• Clinical medication reviews are the level 3 reviews, the highest category. They are conducted by
doctors, CCG pharmacists, specialist nurses and NMPs in the presence of the patient, with full
access to the patient’s medication history and notes.
• Medicines optimisation focuses on a patient-centered approach to care in which the patients’
experience, evidence-based medicine, safe use of medicines and optimal therapy are all
considered, so that patient outcomes can be improved.
Conducting an MUR
• When conducting an MUR, the pharmacist should be able to communicate effectively, which
involves adequate eye-contact, reading of non-verbal cues, removing distractions and holding the
conversation in a private area, such as a consultation room.
• The MUR should begin with an introduction, perhaps by asking a few general questions like how
their day is going, what they are up to recently etc. Then the main body of the MUR should consist
of at first open-ended, then closed questions to identify issues, prioritise them and develop action
plans based on who should be following up what issues.
• Leading questions should be avoided to allow the patient to be truthful and sure in their responses
to your questions. Words such as “how” and “what” are better and less accusatory than “why”.
• Some areas may be sensitive to certain patients, such as age and nature of some adverse effects.
Leaving these sorts of questions until later can be better, as the patient is more relaxed in the
conversation and willing to divulge information.
Title
• Content

More Related Content

PPTX
Ward round participation
PDF
improving-medication-adherence
PPTX
Patient counselling
PPTX
Pharmaceutical Care
PPTX
Ward round participation
PPTX
Medication history interview
PPTX
Patient counseling
PPTX
medication adherence
Ward round participation
improving-medication-adherence
Patient counselling
Pharmaceutical Care
Ward round participation
Medication history interview
Patient counseling
medication adherence

What's hot (20)

PDF
Pharmaceutical care
PDF
ClinPhar-MODULE-2.pdf
PPTX
Drug utilisation evaluation
PPTX
Medication adherence
PPTX
Pharmaceutical care
PPTX
Strategies to overcome barriers of patient counselling
PPT
Ward round kosey
PPTX
anatomy and physiology of ward rounds
PPTX
Clinical Pharmacy - Patient Compliance
PPTX
Journal club -pharmacist intervention in cost saving.
PPT
role of pharmacist in patient compliance
PPTX
(DUE) Drug use evaluation
PPT
Patient compliance simi joju k.
PPTX
Medical adherence
PPTX
Patient Medication History Interview
PPTX
Patient compliance
PPTX
Medication adherence
PDF
Drug Therapy Monitoring
PPTX
Pharmaceutical care
ClinPhar-MODULE-2.pdf
Drug utilisation evaluation
Medication adherence
Pharmaceutical care
Strategies to overcome barriers of patient counselling
Ward round kosey
anatomy and physiology of ward rounds
Clinical Pharmacy - Patient Compliance
Journal club -pharmacist intervention in cost saving.
role of pharmacist in patient compliance
(DUE) Drug use evaluation
Patient compliance simi joju k.
Medical adherence
Patient Medication History Interview
Patient compliance
Medication adherence
Drug Therapy Monitoring
Ad

Viewers also liked (20)

PDF
Super Training
PPTX
Evaluation question 2
PDF
Por qué-se-equivocó-la-mayor-parte-de-los-pronósticos-acerca-del-triunfo-de-d...
PPTX
Cervical Spine Stretching
PPT
Headaches presentation at www.eyenirvaan.com
DOCX
Surfaces and Interfaces
PDF
ЭКСПЕРИМЕНТАЛЬНАЯ МЕТОДОЛОГИЯ
PDF
Apertura petrolera
PPTX
Ο κύκλος του νερού.
PPTX
Syyspäivät 2016 yvonne korenius
PPS
Listing Presentation Right About R.E
PDF
택배서비스1 완성
PPT
Fungi 2
PPTX
Black Mold: How Bad Is It?
PDF
METAS DEL PERÚ AL BICENTENARIO 2021
PPT
Presentation on microbial flora of soil by rahul
PDF
¿Como abordar el diagnóstico y análisis de la cultura en servicios perinatólo...
PPT
Keys to Ending Fibromyalgia
PDF
Presion intraabdominal
PPTX
Angiotc de cuello
Super Training
Evaluation question 2
Por qué-se-equivocó-la-mayor-parte-de-los-pronósticos-acerca-del-triunfo-de-d...
Cervical Spine Stretching
Headaches presentation at www.eyenirvaan.com
Surfaces and Interfaces
ЭКСПЕРИМЕНТАЛЬНАЯ МЕТОДОЛОГИЯ
Apertura petrolera
Ο κύκλος του νερού.
Syyspäivät 2016 yvonne korenius
Listing Presentation Right About R.E
택배서비스1 완성
Fungi 2
Black Mold: How Bad Is It?
METAS DEL PERÚ AL BICENTENARIO 2021
Presentation on microbial flora of soil by rahul
¿Como abordar el diagnóstico y análisis de la cultura en servicios perinatólo...
Keys to Ending Fibromyalgia
Presion intraabdominal
Angiotc de cuello
Ad

Similar to Medicines usage reviews (20)

PPTX
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
PPTX
Rational drug use
PPTX
Patient safety & role of pharmacist
PPTX
Rational Drug USe - Pharmacotherapeutics -1
PPTX
PHAR 415 MANUAL SPRING 015.ppt.........x
PDF
medication adherence.pdf
PDF
Patient medication counselling.
PPTX
Clinical Pharmacy.pptx
PPTX
Drug Utilization review
PDF
RDP-CP-PP.pdf
PPTX
General Discussion on Clinical Pharmacy
PPTX
Prescribed Medication Order and Communication Skills.pptx
PPT
Clinical pharmacist in TB & Renal Ward
PPTX
Drug utilization review 1
PPTX
Introduction to Pharmacotherapeutics.pptx
PPTX
Clinical pharmacy.pptx
PPTX
Hospital formulary development and Rational drug use
PPTX
CPM 481 - Principles & Practice of Clinical Pharmacy.pptx
PPT
RUD and COMPLIANCE
PPT
Rational use of medicines and patient compliance
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Rational drug use
Patient safety & role of pharmacist
Rational Drug USe - Pharmacotherapeutics -1
PHAR 415 MANUAL SPRING 015.ppt.........x
medication adherence.pdf
Patient medication counselling.
Clinical Pharmacy.pptx
Drug Utilization review
RDP-CP-PP.pdf
General Discussion on Clinical Pharmacy
Prescribed Medication Order and Communication Skills.pptx
Clinical pharmacist in TB & Renal Ward
Drug utilization review 1
Introduction to Pharmacotherapeutics.pptx
Clinical pharmacy.pptx
Hospital formulary development and Rational drug use
CPM 481 - Principles & Practice of Clinical Pharmacy.pptx
RUD and COMPLIANCE
Rational use of medicines and patient compliance

More from George Wild (20)

DOCX
Dosage Form Design
DOCX
Introduction to Biopharmaceutics
DOCX
Pharmaceutical Solutions
DOCX
Parenteral Drug Delivery
DOCX
Preformulation
DOCX
Packaging and Stability
DOCX
Disperse Systems
DOCX
Management of Chronic Kidney Disease
PPTX
Bronchodilators and anti inflammatories
PPTX
Vasodilators and vasoconstrictors
PPTX
Contamination control and sterile manufacturing
PPTX
Nasal drug delivery
PPTX
Parenterals
PPTX
Pulmonary drug delivery
PPTX
Alveolar gases and diffusion
PPTX
Innate and adaptive immunity
PPTX
Haematopoesis
PPTX
Anaemia and pathology
PPTX
Acute kidney injury
PPTX
Amino acids, peptides and proteins
Dosage Form Design
Introduction to Biopharmaceutics
Pharmaceutical Solutions
Parenteral Drug Delivery
Preformulation
Packaging and Stability
Disperse Systems
Management of Chronic Kidney Disease
Bronchodilators and anti inflammatories
Vasodilators and vasoconstrictors
Contamination control and sterile manufacturing
Nasal drug delivery
Parenterals
Pulmonary drug delivery
Alveolar gases and diffusion
Innate and adaptive immunity
Haematopoesis
Anaemia and pathology
Acute kidney injury
Amino acids, peptides and proteins

Recently uploaded (20)

PDF
CASE PRESENTATION1.pdf bipolar disorder in which both mania and depression h...
PDF
odontologia na oncologia - carie de radiação
DOCX
Advanced Nursing Procedures.....realted to advance nursing practice M.Sc. 1st...
PPTX
SlideEgg_100085- World Mental Health Day.pptx
PPTX
applied physics dental materials basic principles
PPTX
CLASS III MALOCCLUSION IN ORTHODONTICS
PPTX
ATIBACTERIAL. PENICILLINS AND CEPHALOSPORINS.pptx
PPTX
Right Lateral Medullary Syndrome (1).pptx
PPT
Immune System presentation for high school
PPTX
Maternal and child health. The normal new born.pptx
PPTX
Pharmaco vigilance for BAMS according to NCISM
PPTX
Approach_to_Child_with_Poisoning_Presentation (1).pptx
PDF
ICU Main Equipments and its explanations
PPTX
The Principle of Naturopathy Self-healing, toxin removal and balance
PPTX
Common Bacterial infections-converted_64bcdc4f77a3b7b90bdeb611f66c6ddd.pptx
PPT
toxicosis in pregnancy preeclampcia eclampcia.ppt
PDF
Liver Cirrhosis: Causes, Symptoms, Stages & Expert Treatment in Pune
PPTX
ANTICHOLINERGICS drugs which are used as emergency and pre medication drugs i...
PPT
NIPT panel discussion HHI 09.12.2017 modified.ppt
PDF
02. SW - Cellular Adaptations for healthcare
CASE PRESENTATION1.pdf bipolar disorder in which both mania and depression h...
odontologia na oncologia - carie de radiação
Advanced Nursing Procedures.....realted to advance nursing practice M.Sc. 1st...
SlideEgg_100085- World Mental Health Day.pptx
applied physics dental materials basic principles
CLASS III MALOCCLUSION IN ORTHODONTICS
ATIBACTERIAL. PENICILLINS AND CEPHALOSPORINS.pptx
Right Lateral Medullary Syndrome (1).pptx
Immune System presentation for high school
Maternal and child health. The normal new born.pptx
Pharmaco vigilance for BAMS according to NCISM
Approach_to_Child_with_Poisoning_Presentation (1).pptx
ICU Main Equipments and its explanations
The Principle of Naturopathy Self-healing, toxin removal and balance
Common Bacterial infections-converted_64bcdc4f77a3b7b90bdeb611f66c6ddd.pptx
toxicosis in pregnancy preeclampcia eclampcia.ppt
Liver Cirrhosis: Causes, Symptoms, Stages & Expert Treatment in Pune
ANTICHOLINERGICS drugs which are used as emergency and pre medication drugs i...
NIPT panel discussion HHI 09.12.2017 modified.ppt
02. SW - Cellular Adaptations for healthcare

Medicines usage reviews

  • 2. Medicines Reconciliation • The aim of medicines reconciliation in a hospital setting is to ensure that the prescribed medicines correspond to those that the patient was taking before admission; it is more than just taking a drug history, and requires consideration of the three C’s; checking, collecting and communicating. • Medicines reconciliation seeks to minimise harm to the patient caused by medication errors, prescribing errors and missed doses, whilst simultaneously reducing admissions and readmissions that are caused by medication harm. It provides prescribers with a fuller information timeline that helps improve patient safety.
  • 3. The Three C’s • Collecting a medication background, checking current medications against prescribed medications/medicines bought in with the patient, and communicating any changes or discrepancies is the basis of how medicines reconciliation can provide benefit to patients. • Sources of drug history include; medicines the patient has bought in with them, prescriptions the patient has on them, verbal communication with the patient, verbal communication with a patients’ relative that is present, information obtained through electronic databases and phone calls to GPs or pharmacies. • Checking medications is important in the detection of intended changes, and unintended changes. Intended changes to medication will have been agreed with the prescriber, whereas unintended changes can arise due to errors, omissions and additions. • Communication is important, so that the patient is involved in their care and can make choices where appropriate. Consent is also important in this regard. The clinician caring for the patient should be free to discuss discrepancies, alter prescriptions if necessary and inform the patient about changes. Changes should also be documented on the patient’s medical notes, the patient’s drug chart and should be written in the hospital discharge summary.
  • 4. MUR • Medicines Usage Reviews (MURs) were introduced in 2005 as an advanced service for community pharmacies. They focus on making sure patients understand how to use their medications, when to use them and why they must use them. • Pharmacists can decide which patients to offer MURs to, but at least half of the patients must fall under National Patient Targets. • National Patient Targets are groups of patients to which MURs should be offered, and include the following groups; those on at-risk medications (i.e. anticoagulants, NSAIDs, antiplatelets and diuretics); patients with a respiratory disease; patients who have recently been discharged from hospital, having had a medication change during their stay; and patients with or who are at risk of cardiovascular disease and regularly being prescribed at least four medicines. • An MUR is different from Clinical Medication Reviews and Medication Reviews. The former is consultation undertaken to assess patient’s illness and drug treatment (not conducted by non- prescribing pharmacists). The latter is a review undertaken to optimise impact of therapy, reduce harm caused by medications, and reduce wastage. • MURs allow the patient to check their understanding of their own condition(s) and a professional to check the effective use of medicines. The pharmacist is ideally placed to detect potential formulation issues, and recommend changes to dose, strength or product. They are also well- placed to identify adverse effects that may require reporting.
  • 5. Levels of Review • MURs are level 1 reviews, that are conducted by pharmacists in the presence of the patient, with no access to patient notes. • Medication reviews are level 2 services that are conducted by doctors, specialist nurses, CCG pharmacists and NMPs in the absence of the patient, with access to full patient records. • Clinical medication reviews are the level 3 reviews, the highest category. They are conducted by doctors, CCG pharmacists, specialist nurses and NMPs in the presence of the patient, with full access to the patient’s medication history and notes. • Medicines optimisation focuses on a patient-centered approach to care in which the patients’ experience, evidence-based medicine, safe use of medicines and optimal therapy are all considered, so that patient outcomes can be improved.
  • 6. Conducting an MUR • When conducting an MUR, the pharmacist should be able to communicate effectively, which involves adequate eye-contact, reading of non-verbal cues, removing distractions and holding the conversation in a private area, such as a consultation room. • The MUR should begin with an introduction, perhaps by asking a few general questions like how their day is going, what they are up to recently etc. Then the main body of the MUR should consist of at first open-ended, then closed questions to identify issues, prioritise them and develop action plans based on who should be following up what issues. • Leading questions should be avoided to allow the patient to be truthful and sure in their responses to your questions. Words such as “how” and “what” are better and less accusatory than “why”. • Some areas may be sensitive to certain patients, such as age and nature of some adverse effects. Leaving these sorts of questions until later can be better, as the patient is more relaxed in the conversation and willing to divulge information.